• |
  • |
  • |
  • |
Donate

Project

PHARM - YAMO Study

Center:
Fiscal Year:
2023
Contact Information:
Project Description:
A Randomized, Double - Blind, Chronic Dosing (12-Weeks), Two-Period , Placebo-Controlled, Crossover, Multi-Center Study to Assess the Efficacy, Safety and Tolerability of Two Doses of L1-79 for the Treatment of the Core Deficits in Social - Communication Interaction in Adolescents and Young Adults with Autism Spectrum Disorder.
Keyword(s):
Core Function(s):
Performing Research or Evaluation, Developing & Disseminating Information
Area of Emphasis
Quality Assurance, Health-Related Activities
Target Audience:
Family Members/Caregivers, Adults with Disabilities, Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Racial or Ethnic Minorities, Disadvantaged Circumstances
Primary Target Audience Geographic Descriptor:
Single-County, Mulit-County, State, Regional
Funding Source:
COVID-19 Related Data:
N/A